help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, R. N.
Right arrow Articles by Radovick, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, R. N.
Right arrow Articles by Radovick, S.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 10 4832-4839
Copyright © 2003 by The Endocrine Society

Enhanced Repression by HESX1 as a Cause of Hypopituitarism and Septooptic Dysplasia

Ronald N. Cohen, Laurie E. Cohen, Diego Botero, Christine Yu, Angela Sagar, Magdalena Jurkiewicz and Sally Radovick

Section of Endocrinology (R.N.C., C.Y., A.S., M.J.), Department of Medicine, University of Chicago, Chicago, Illinois 60637; Division of Endocrinology (L.E.C., D.B.), Department of Medicine, Children’s Hospital, Boston, Massachusetts 02115; and Section of Pediatric Endocrinology (C.Y., S.R.), Department of Pediatrics, University of Chicago, Chicago, Illinois 60637

Address all correspondence and requests for reprints to: Ronald Cohen, M.D., Section of Endocrinology, Department of Medicine, 5841 South Maryland Avenue, MC 1027, Chicago, Illinois 60637. E-mail: roncohen{at}medicine.bsd.uchicago.edu.

HESX1 is a paired-like homeodomain transcription factor that functions as a repressor of PROP1-mediated gene stimulation. Mutations in HESX1 have been implicated in cases of septooptic dysplasia and congenital hypopituitarism. All mutations in HESX1 identified to date have resulted in impaired DNA binding and defective HESX1 action. We have identified a novel HESX1 mutation in genomic nucleotide position 1684 (g.1684delG), which results in a mutant protein with increased DNA binding. In turn, this mutation causes increased repression of PROP1-dependent gene activity. These data suggest that enhancement of transcriptional repression during pituitary organogenesis is a novel mechanism for the development of congenital pituitary disorders.

This work was supported by grants from the National Institutes of Health (to R.N.C., L.E.C., and S.R.) and the Genentech Foundation for Growth and Development (to L.E.C.). M.J. was the recipient of a Howard Hughes Medical Institute Summer Student Research Fellowship.

Abbreviations: CMV, Cytomegalovirus; E13, embryonic d 13; NCoR, nuclear corepressor; PRL, prolactin; SOD, septooptic dysplasia; UAS, upstream activating sequence.




This article has been cited by other articles:


Home page
DMMHome page
E. Sajedi, C. Gaston-Massuet, M. Signore, C. L. Andoniadou, D. Kelberman, S. Castro, H. C. Etchevers, D. Gerrelli, M. T. Dattani, and J. P. Martinez-Barbera
Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism
Dis. Model. Mech., November 1, 2008; 1(4-5): 241 - 254.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
D. Kelberman and M. T. Dattani
Hypothalamic and pituitary development: novel insights into the aetiology
Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S3 - S14.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. E. G. McNay, J. P. Turton, D. Kelberman, K. S. Woods, R. Brauner, A. Papadimitriou, E. Keller, A. Keller, N. Haufs, H. Krude, et al.
HESX1 Mutations Are an Uncommon Cause of Septooptic Dysplasia and Hypopituitarism
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 691 - 697.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M.-L. Sobrier, M. Maghnie, M.-P. Vie-Luton, A. Secco, N. di Iorgi, R. Lorini, and S. Amselem
Novel HESX1 Mutations Associated with a Life-Threatening Neonatal Phenotype, Pituitary Aplasia, but Normally Located Posterior Pituitary and No Optic Nerve Abnormalities
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4528 - 4536.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Hashimoto, R. N. Cohen, M. Yamada, K. R. Markan, T. Monden, T. Satoh, M. Mori, and F. E. Wondisford
Cross-talk between Thyroid Hormone Receptor and Liver X Receptor Regulatory Pathways Is Revealed in a Thyroid Hormone Resistance Mouse Model
J. Biol. Chem., January 6, 2006; 281(1): 295 - 302.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society